hematopoietic-stem-cell-transplantation

Documents about hematopoietic-stem-cell-transplantation

• Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients#904630ClinicalTrials.gov
• Danazol treatment for poor graft function after hematopoietic stem cell transplantation: a single centre experience#250603IRIS
• EBV mRNA Vaccine for the Prevention of EBV-Related Diseases After Allo-HSCT#394627ClinicalTrials.gov
• Clinical and Microbiological Insights Into Invasive Fusariosis Following Allogeneic Hematopoietic Stem Cell Transplantation: A 15-Year Single-Center Analysis.#796710NCBI PubMed Central
• Haploidentical Donor vs mMUD in Hematological Malignancies#844431ClinicalTrials.gov
• Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma#854851ClinicalTrials.gov
• Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients#864911ClinicalTrials.gov
• T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias#890010ClinicalTrials.gov
• Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers#830627ClinicalTrials.gov
• Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients#1010871ClinicalTrials.gov
• Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci#125898ClinicalTrials.gov
• Lymphedema in patients with X-linked severe combined immunodeficiency#246823HAL (France)
• TFBC Combined With UCBT in the Treatment of High-risk Malignant Hematological Diseases#303715ClinicalTrials.gov
• Cutaneous graft-versus-host disease: From acute reactions to chronic sequelae#413874ARPHA OAI-PMH Endpoint
• BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT#843523ClinicalTrials.gov
• Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients#860229ClinicalTrials.gov
• EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients#863366ClinicalTrials.gov
• Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer#871074ClinicalTrials.gov
• Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled Trial#825544ClinicalTrials.gov
• T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR#906422ClinicalTrials.gov
• Chidamide Maintenance to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute T-Lymphoblastic Leukemia/Lymphoma#967080ClinicalTrials.gov
• Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance#865985ClinicalTrials.gov
• Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function#884827ClinicalTrials.gov
• Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.#892744ClinicalTrials.gov
• Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients#844275ClinicalTrials.gov
• Phase II Trial of Pentostatin and Targeted Busulfan#906437ClinicalTrials.gov
• Younger vs. Older Donors in Allo-HSCT: TTE#995568ClinicalTrials.gov
• Methyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic Hematopoietic Stem Cell Transplantation#1032879ClinicalTrials.gov
• Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT#829306ClinicalTrials.gov
• Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome#884985ClinicalTrials.gov
• Does Desire to Pursue Pleasurable Activities Matter? The Impact of Pretransplantation Anhedonia on Quality of Life and Fatigue in Hematopoietic Stem Cell Transplantation.#382401NCBI PubMed Central
• MRD Response-adapted Allo-HSCT for Adverse-risk AML#800228ClinicalTrials.gov
• Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma#860982ClinicalTrials.gov
• Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma#995586ClinicalTrials.gov
• Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD#835884ClinicalTrials.gov
• NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)#806317ClinicalTrials.gov
• Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT#872292ClinicalTrials.gov
• Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT#893857ClinicalTrials.gov
• Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation#910024ClinicalTrials.gov
• Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome#405138ClinicalTrials.gov
• Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant#886816ClinicalTrials.gov
• MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD#874660ClinicalTrials.gov
• An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells#812479ClinicalTrials.gov
• Novel insights from a large cohort: Elucidating incidence, risk factors, treatment, and prognostic predictors in autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.#135791NCBI PubMed Central
• Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT#842829ClinicalTrials.gov
• A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.#844724ClinicalTrials.gov
• Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia#914037ClinicalTrials.gov
• Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia#234425ClinicalTrials.gov
• Liver Stiffness Measurement Predicts VOD/SOS Development (ELASTOVOD ITALIAN MULTICENTRIC STUDY)#842711ClinicalTrials.gov
• Haplo HCT vs Haplo-cord HCT for Patients With AML#839801ClinicalTrials.gov